73776-02-0

Upstream product

• 103396-04-9 N,N'-{2,2'-[propane-1,3-diylbis(oxy)]bis(2,1-phenylene)}diacetamide 
• 614-80-2 2-(acetylamino)phenol 

Downstream Products

• 93274-31-8 C₂₉H₃₀N₂O₆S₂ 
• 126292-71-5 16,17-dihydro-5H,15H-7-p-nitrophenyldibenzo<1,11,4,5,7,8>dioxatetraazacyclotetradecine 
• 1131148-01-0 1,1'-{4,4'-[propane-1,3-diylbis(oxy)]bis(4,1-phenylene)}bis[3-(4-methoxyphenyl)urea] 
• 295804-60-3 2-{[2-(3-{2-[N'-(1-ethoxycarbonyl-2-oxo-2-phenyl-ethylidene)-hydrazino]-phenoxy}-propoxy)-phenyl]-hydrazono}-3-oxo-3-phenyl-propionic acid ethyl ester 
• 295804-53-4 2-{[2-(3-{2-[N'-(1-ethoxycarbonyl-2-oxo-propylidene)-hydrazino]-phenoxy}-propoxy)-phenyl]-hydrazono}-3-oxo-butyric acid ethyl ester 
• 295804-81-8 3-{[2-(3-{2-[N'-(1-acetyl-2-oxo-propylidene)-hydrazino]-phenoxy}-propoxy)-phenyl]-hydrazono}-pentane-2,4-dione 

Relevant academic research and scientific papers

QSAR modeling, synthesis and bioassay of diverse leukemia RPMI-8226 cell line active agents

A rigorous QSAR modeling procedure employing CODESSA PRO descriptors has been utilized for the prediction of more efficient anti-leukemia agents. Experimental data concerning the effect on leukemia RPMI-8226 cell line tumor growth of 34 compounds (treated

New Synthesis of Macrocyclic Crown-Formazans from Pyruvic Acid Derivatives

The macrocyclic crown-formazans 7a-c, 12a-g were prepared by the azo-coupling of the appropriate bis-diazonium salts 4a-c with pyruvic acid and arylpyruvic acids 8a-c.The ready accessability of the latters offers an easy access towards 1,5-symmetrically d